⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31351972 | 1.00 | — | — | |
| SCHEMBL8182354 | 0.78 | — | — | |
| SCHEMBL6719860 | 0.77 | PDE4A (0.31) | — | |
| SCHEMBL2128819 | 0.75 | — | — | |
| SCHEMBL25300794 | 0.74 | — | — | |
| SCHEMBL31462873 | 0.74 | ADORA2A (0.33) | — | |
| SCHEMBL1661085 | 0.74 | — | — | |
| SCHEMBL19743731 | 0.74 | — | — | |
| SCHEMBL31351992 | 0.74 | — | — | |
| SCHEMBL19743771 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3472176-B1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | SPHAERA PHARMA PRIVATE LTD (IN) | 2024-05-15 | — | — | EP | claimed |
| US-20210177801-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | EPIRIUM BIO INC. | 2021-06-17 | — | — | US | claimed |
| US-10898465-B2 | Utility of (+) epicatechin and their analogs | EPIRIUM BIO INC. (US) | 2021-01-26 | — | — | US | claimed |
| US-20190247359-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | EPIRIUM BIO INC. | 2019-08-15 | — | — | US | claimed |
| EP-3472176-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | Sphaera Pharma Pvt. Ltd. (IN) | 2019-04-24 | — | — | EP | claimed |
| WO-2017221269-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | SPHAERA PHARMA PVT. LTD., (IN) | 2017-12-28 | — | — | WO | claimed |
| CN-120004810-A | Trifluoroethyl thioether compound containing pyrimidyl amine | 湖南化工研究院有限公司 | 2025-05-16 | — | — | CN | disclosed |
| WO-2025051148-A1 | NITROGEN-CONTAINING HETEROARYL COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 北京鞍石生物科技股份有限公司 | 2025-03-13 | — | — | WO | disclosed |
| EP-3472176-B1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | SPHAERA PHARMA PRIVATE LTD (IN) | 2024-05-15 | — | — | EP | disclosed |
| CN-109906224-B | Triazolopyridine compounds and uses thereof | 诺华股份有限公司 | 2022-02-25 | — | — | CN | disclosed |
| US-20210177801-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | EPIRIUM BIO INC. | 2021-06-17 | — | — | US | disclosed |
| US-10898465-B2 | Utility of (+) epicatechin and their analogs | EPIRIUM BIO INC. (US) | 2021-01-26 | — | — | US | disclosed |
| US-10689378-B2 | Triazolopyridine compounds and uses thereof | NOVARTIS AG (CH) | 2020-06-23 | — | — | US | disclosed |
| EP-3472161-B1 | TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2020-03-25 | — | — | EP | disclosed |
| US-20190247359-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | EPIRIUM BIO INC. | 2019-08-15 | — | — | US | disclosed |
| US-20190202828-A1 | TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2019-07-04 | — | — | US | disclosed |
| EP-3472176-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | Sphaera Pharma Pvt. Ltd. (IN) | 2019-04-24 | — | — | EP | disclosed |
| EP-3472161-A1 | TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF | Novartis AG (CH) | 2019-04-24 | — | — | EP | disclosed |
| WO-2017221269-A1 | UTILITY OF (+) EPICATECHIN AND THEIR ANALOGS | SPHAERA PHARMA PVT. LTD., (IN) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017221092-A1 | TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2017-12-28 | — | — | WO | disclosed |